OGEN · Oragenics Inc
$0.53
+0.01 (+1.90%)
At close · Aug 26
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Considering our recurring losses, accumulated deficit, and negative cash flows, the report of our independent registered public accounting firm on our consolidated financial statements for the year ended December 31, 2025, included an explanatory paragraph raising substantial doubt about our ability to continue as a going concern. ... These factors raise substantial doubt regarding our ability to continue as a going concern. We plan to pursue additional financing to mitigate liquidity risk; however, substantial doubt about our ability to continue as a going concern remains unless and until we obtain sufficient capital to fund operations beyond the current planning horizon. ... Based on these factors, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.37M
Shares
4.51M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Janet Huffman | Chief Financial Officer, Chief Executive Officer | $609,157 |
| Joseph Redmond | Former President and Interim Principal Executive Officer | $198,000 |
| Kimberly M. Murphy | — | — |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Joseph Redmond | Former President and Interim Principal Executive Officer | $464,141 |
| Janet Huffman | Chief Financial Officer, Interim Chief Executive Officer | $363,700 |
| Former Chief | Executive Officer and President | $280,924 |
| Kimberly M. Murphy | Former Chief Executive Officer and President | $280,924 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kimberly M. Murphy | Former Chief Executive Officer and President | $592,150 |
| Janet Huffman | Chief Financial Officer, Interim Chief Executive Officer | $420,346 |
| Joseph Redmond | Former President and Interim Principal Executive Officer | $343,800 |
| Dr. Martin Handfield | Senior Vice President Discovery Research | $255,988 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Kimberly M. Murphy | Chief Executive Officer and President | $484,836 |
| Michael O. Sullivan | Chief Financial Officer | $434,687 |
| Dr. Martin Handfield | Senior Vice President Discovery Research | $299,771 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Dr. Alan Joslyn | President and Chief Executive Officer | $924,427 |
| Michael O. Sullivan | Chief Financial Officer | $682,428 |
| Dr. Martin Handfield | Senior Vice President Discovery Research Former Officer: | $550,790 |
| Kimberly M. Murphy | Chief Executive Officer and President | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Dr. Alan | CEO | $902,639 |
| Dr. Alan Joslyn | President and Chief Executive Officer | $902,639 |
| Michael O. Sullivan | Interim Principal Executive Officer and Chief Financial Officer | $532,210 |
| Dr. Martin Handfield | Senior Vice President Discovery Research Former Officer: | $456,851 |
| Dr. Martin | — | $456,851 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Dr. Alan | CEO | $488,394 |
| Dr. Alan Joslyn | (former President and Chief Executive Officer) | $488,394 |
| Michael O. Sullivan | Chief Financial Officer and Interim Principal Executive Officer | $313,307 |
| Dr. Martin Handfield | Senior Vice President Discovery Research | $244,916 |
| Dr. Martin | — | $244,916 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Dr. Alan Joslyn | President and Chief Executive Officer | $834,983 |
| Michael O. Sullivan | Chief Financial Officer | $505,568 |
| Dr. Martin Handfield | Senior Vice President Discovery Research | $423,148 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Spencer | Chief Financial Officer | Appointed | 2026-07-06 |
| Natasha Giordano | Board | Appointed | 2025-09-02 |
| Janet Huffman | Chief Executive Officer | Appointed | 2025-05-02 |
| Bruce Cassidy | director | Resigned | 2025-01-17 |
| Janet Huffman | Interim Chief Executive Officer | Appointed | 2025-01-17 |
| Janet Huffman | Interim Principal Executive Officer and President | Appointed | 2024-12-16 |
| J. Michael Redmond | Interim Principal Executive Officer and President | Terminated | 2024-12-16 |
| Michael Redmond | Interim Principal Executive Officer | Appointed | 2024-02-12 |
| Charlie Pope | Executive Chairman | Appointed | 2024-02-12 |
| Kimberly Murphy | Chief Executive Officer | Terminated | 2024-02-12 |
| Joseph Michael Redmond | President | Appointed | 2023-12-29 |
| John Gandolfo | member of the Board of Directors | Appointed | 2023-10-05 |
| Bruce Cassidy | member of the Board of Directors | Appointed | 2023-10-05 |
| Janet Huffman | Chief Financial Officer | Appointed | 2023-03-08 |
| Kimberly Murphy | Interim Chief Financial Officer, Secretary and Treasurer | Appointed | 2022-12-16 |
| Michael Sullivan | Chief Financial Officer, Secretary and Treasurer | Resigned | 2022-12-16 |
| Michael Sullivan | Chief Financial Officer | Resigned | 2022-11-16 |
| Kimberly M. Murphy | President and Chief Executive Officer | Appointed | 2022-06-23 |
| Kimberly Murphy | President and Chief Executive Officer | Appointed | 2022-06-23 |
| Alan Joslyn | director | Resigned | 2021-05-03 |
| Alan Joslyn | President, Chief Executive Officer | Resigned | 2021-05-03 |
| Kim Murphy | the Board will appoint Kim Murphy to fill such vacancy until her successor is duly elected or until her earlier resignation, rem | Appointed | 2020-05-04 |
| Kim Murphy | board of directors | Appointed | 2020-05-04 |
Key facts
CIK
1174940
CUSIP
684023609
13F (30d)
17 filings
15 filers
Visit website
Investor relations